NCT04088422
Recruiting
Not Applicable
Prospective, Observational Study on Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Lymphoma Management
ConditionsMature B-Cell Lymphoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mature B-Cell Lymphoma
- Sponsor
- Ruijin Hospital
- Enrollment
- 320
- Locations
- 1
- Primary Endpoint
- progression free survival
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.
Investigators
Zhao Weili
Professor
Ruijin Hospital
Eligibility Criteria
Inclusion Criteria
- •Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
- •18 years or older
Exclusion Criteria
- •Chemotherapy before
- •Other tumors
Outcomes
Primary Outcomes
progression free survival
Time Frame: 2-year
Secondary Outcomes
- overall survival(2-year)
- Complete Response rate(6 weeks after treatment)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Liquid Biopsy in High-grade Gliomas and MeningiomasHigh Grade GliomaHigh Grade MeningiomaNCT05630664IRCCS San Raffaele90
Unknown
Not Applicable
A Prospective, Observational Trial on the Diagnostic and Prognostic of LMLung NeoplasmsMeningeal CarcinomatosisNCT02607605Sun Yat-sen University10
Completed
Not Applicable
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic CancerMetastatic Non-Small Cell Lung CarcinomaMetastatic Colorectal CancerMetastatic Breast CancerNCT03892096Cadex Genomics130
Completed
Not Applicable
Prospective study for usefulness of plasma DNA on prediction of third generation EGFR tyrosine kinase inhibitorson-small cell lung cancerJPRN-UMIN000025930Division of Respiratory Medicine, Saga University Hospital57
Unknown
Not Applicable
Cell-free DNA Quantification for Predictive Marker of Palliative ChemotherapyCell-Free Nucleic AcidsBiomarkersFluorescencePalliative ChemotherapyNCT05227950Pusan National University Yangsan Hospital100